公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2015 | Towards an HBV cure: State-of-the-art and unresolved questions-report of the ANRS workshop on HBV cure | Zeisel M.B.; Lucifora J.; Mason W.S.; Sureau C.; Beck J.; Levrero M.; Kann M.; Knolle P.A.; Benkirane M.; Durantel D.; Michel M.-L.; Autran B.; Cosset F.-L.; Strick-Marchand H.; Trépo C.; JIA-HORNG KAO ; Carrat F.; Lacombe K.; Schinazi R.F.; Barré-Sinoussi F.; Delfraissy J.-F.; Zoulim F. | Gut | 225 | 202 | |
2020 | Towards elimination of viral hepatitis in Taiwan by 2025: In memory of Professor Ding-Shinn Chen (1943-2020) | HUNG-CHIH YANG ; JIA-HORNG KAO | Journal of the Formosan Medical Association | 3 | 2 | |
2011 | Transient elastography to assess hepatic fibrosis in hemodialysis chronic hepatitis C patients | CHEN-HUA LIU ; Liang, Cheng-Chao; KAI-WEN HUANG ; CHUN-JEN LIU ; Chen, Shih-I; JOU-WEI LIN ; Hung, Peir-Haur; Tsai, Hung-Bin; Lai, Ming-Yang; PEI-JER CHEN ; Chen, Jun-Herng; DING-SHINN CHEN ; JIA-HORNG KAO | Clinical journal of the American Society of Nephrology : CJASN | 71 | 69 | |
1992 | Transient immunoglobulin M antibody response to hepatitis C virus capsid antigen in posttransfusion hepatitis C: Putative serological marker for acute viral infection | PEI-JER CHEN ; JIN-TOWN WANG ; Hwang L.-H.; Yang Y.-H.; Hsieh C.-L.; JIA-HORNG KAO ; JIN-CHUAN SHEU ; Lai M.-Y.; Wang T.-H.; DING-SHINN CHEN | Proceedings of the National Academy of Sciences of the United States of America | 61 | 59 | |
2021 | Transition rates to cirrhosis and liver cancer by age, gender, disease and treatment status in Asian chronic hepatitis B patients | Liu M.; TAI-CHUNG TSENG ; Jun D.W.; Yeh M.-L.; Trinh H.; Wong G.L.H.; Chen C.-H.; Peng C.-Y.; Kim S.E.; Oh H.; Kwak M.-S.; Cheung M.; Toyoda H.; Hsu Y.-C.; Jeong J.Y.; Yoon E.L.; Ungtrakul T.; Zhang J.; Xie Q.; Ahn S.B.; Enomoto M.; Shim J.-J.; Cunningham C.; Jeong S.W.; Cho Y.K.; Ogawa E.; Huang R.; Lee D.-H.; Takahashi H.; Tsai P.-C.; Huang C.-F.; Dai C.-Y.; Tseng C.-H.; Yasuda S.; Kozuka R.; Li J.; Wong C.; Wong C.C.; Zhao C.; Hoang J.; Eguchi Y.; Wu C.; Tanaka Y.; Gane E.; Tanwandee T.; Cheung R.; Yuen M.-F.; Lee H.-S.; Yu M.-L.; JIA-HORNG KAO ; Yang H.-I.; Nguyen M.H. | Hepatology International | 15 | 14 | |
1996 | Transmission of hepatitis C virus between spouses: The important role of exposure duration | JIA-HORNG KAO ; Hwang Y.-T.; PEI-JER CHEN ; PEI-MING YANG ; Lai M.-Y.; Wang T.-H.; DING-SHINN CHEN | American Journal of Gastroenterology | 83 | 66 | |
2000 | Transmission of hepatitis C virus in Asia: Past and present perspectives | JIA-HORNG KAO ; DING-SHINN CHEN | Journal of Gastroenterology and Hepatology (Australia) | 75 | 67 | |
2006 | Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan | CHUN-JEN LIU ; SHYH-CHYI LO ; JIA-HORNG KAO ; Tseng P.-T.; Lai M.-Y.; YEN-HSUAN NI ; Shiou-Hwei Yeh ; PEI-JER CHEN ; DING-SHINN CHEN | Journal of Hepatology | 98 | 88 | |
2015 | Treating Immune-tolerant Hepatitis B | TAI-CHUNG TSENG ; JIA-HORNG KAO | Journal of viral hepatitis | 39 | 32 | |
2010 | Treatment of chronic hepatitis B in Asia-Pacific countries: Is the Asia-Pacific consensus statement being followed? | Sung J.J.Y.; Amarapurkar D.; Chan H.L.Y.; Cheng J.; JIA-HORNG KAO ; Han K.-H.; Piratvisuth T. | Antiviral Therapy | 9 | 9 | |
2017 | Treatment of de novo hepatitis C virus-related fibrosing cholestatic hepatitis after orthotopic heart transplantation by ledipasvir and sofosbuvir | CHEN-HUA LIU ; YIH-SHARNG CHEN ; SHOEI-SHEN WANG ; JIA-HORNG KAO | Journal of the Formosan Medical Association | 4 | 6 | |
2011 | Treatment of hepatitis C virus infection in patients with end-stage renal disease | CHEN-HUA LIU ; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 67 | 67 | |
2013 | Treatment options for dual HCV/HBV coinfection | CHUN-JEN LIU ; JIA-HORNG KAO | Emerging Therapeutic Options for Hepatitis C | 0 | 0 | |
2022 | Treatment outcomes of sofosbuvir/velpatasvir/voxilaprevir among NS5A inhibitor-experienced patients with hepatitis C: Real-world data from a multicenter Asian registry | Wong Y.J.; Kumar R.; Kumar R.; Tan J.; CHEN-HUA LIU ; Hui V.W.-K.; Tan S.S.; JIA-HORNG KAO ; Wong G.L.-H.; Thurairajah P.H. | Journal of Gastroenterology and Hepatology (Australia) | 4 | 2 | |
2014 | Triple therapy for hepatitis C virus infection in patients receiving hemodialysis | CHEN-HUA LIU ; JIA-HORNG KAO | Annals of Internal Medicine | 1 | 1 | |
2003 | TT virus infection in healthy children, children after blood transfusion, and children with non-A to E hepatitis or other liver diseases in Taiwan | HONG-YUAN HSU ; YEN-HSUAN NI ; HUEY-LING CHEN ; JIA-HORNG KAO ; MEI-HWEI CHANG | Journal of Medical Virology | 35 | 24 | |
2000 | TT virus infection in patients with chronic hepatitis B or C: Influence on clinical, histological and virological features | JIA-HORNG KAO ; Chen W.; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Journal of Medical Virology | 36 | | |
2018 | Twelve-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin for non-cirrhotic HCV genotype 1 patients: A phase 2 study | JIA-HORNG KAO ; Yu M.-L.; Chen C.-Y.; Peng C.-Y.; Chen M.-Y.; Tang H.; Chen Q.; Wu J.J. | Journal of Gastroenterology and Hepatology (Australia) | 15 | 11 | |
2007 | Two Decades of Universal Hepatitis B Vaccination in Taiwan: Impact and Implication for Future Strategies | YEN-HSUAN NI ; LI-MIN HUANG ; MEI-HWEI CHANG ; CHUNG-JEN YEN ; CHUN-YI LU ; You S.; JIA-HORNG KAO ; Lin Y.; HUEY-LING CHEN ; HONG-YUAN HSU ; DING-SHINN CHEN | Gastroenterology | 274 | 252 | |
2005 | Typhoid fever and typhoid hepatitis in Taiwan | Wang J.-L.; JIA-HORNG KAO ; Tseng S.-P.; LEE-JENE TENG ; Ho S.-W.; PO-REN HSUEH | Epidemiology and Infection | 10 | 5 | |